Results 261 to 270 of about 158,005 (297)
Some of the next articles are maybe not open access.
Shifting views on lipid lowering therapy
BMJ, 2010Harlan Krumholz and Rodney Hayward argue that preventive cardiology should be based as much as possible on strategies that are known to improve patient outcomes rather than focusing on ...
Harlan M, Krumholz, Rodney A, Hayward
openaire +2 more sources
Combination lipid-lowering therapy in diabetes
Current Diabetes Reports, 2003Owing to the National Cholesterol Education Program Adult Treatment Panel III recommendations that patients with diabetes require a low-density lipoprotein (LDL) less than 100 mg/dL and a non-high-density lipoprotein (HDL) less than 130 mg/dL, frequently, combination lipid-lowering therapy is required.
openaire +2 more sources
Comparative effects of lipid-lowering therapies
Progress in Cardiovascular Diseases, 2004The pharmacologic regulation of lipid metabolism in patients with dyslipidemia is unequivocally associated with significant reductions in risk for cardiovascular morbidity and mortality. A number of therapeutic drug classes have been developed in an effort to ever more precisely and intensively modulate lipid metabolism.
Michael H, Davidson, Peter P, Toth
openaire +2 more sources
1999
Prevention of coronary heart disease is not only important from the public health point of view. Efforts to prevent disease test our fundamental concepts of etiology. Atherosclerotic coronary heart disease is a complex process of atherosclerotic plaque accumulation and interaction with a thrombotic and fibrinolytic system, which may or may not ...
openaire +1 more source
Prevention of coronary heart disease is not only important from the public health point of view. Efforts to prevent disease test our fundamental concepts of etiology. Atherosclerotic coronary heart disease is a complex process of atherosclerotic plaque accumulation and interaction with a thrombotic and fibrinolytic system, which may or may not ...
openaire +1 more source
Advances in Lipid-Lowering Therapy in Atherosclerosis
2001The accrued evidence that lipid-lowering therapy limits the progression of atherosclerosis and reduces CAD events is overwhelming. The focus has been on LDL-C reduction with statins, but recent evidence also stresses the importance of raising HDL-C and reducing triglyceride-rich lipoproteins (TRL).
openaire +2 more sources
Lipid lowering therapy for adults with diabetes.
Australian family physician, 2008The number of adults in Australia with diabetes has trebled over the past 2 decades. Diabetes confers an increased risk of cardiovascular disease (CVD) and CVD is the leading cause of morbidity and mortality in patients with diabetes. Hyperlipidaemia occurs commonly in people with diabetes and is an independent CVD risk factor.
Jackowski, Leslie +2 more
openaire +2 more sources
Complementary lipid-lowering therapies
American Journal of Health-System Pharmacy, 1999openaire +2 more sources
[Update of lipid lowering therapy].
Praxis, 2008Dyslipidemia is one of the most important cardiovascular risk factors. Accordingly preventive measures to normalize lipids are of great importance. The indication for a lipid lowering therapy according to current guidelines focuses on the identification of a patient's global risk, i.e. the contribution of all major cardiovascular risk factors.
W F, Riesen, R C, Mordasini
openaire +1 more source